Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Encarnación Reche Santos"'
Autor:
Angel Segura Huerta, Encarnación Reche Santos, Gema Bruixola Campos, Carmen Salvador Coloma, Oscar Niño Gómez
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 2, Pp 391-396 (2013)
Introduction: To date, there are no guidelines for a rational and more favourable sequence of treatment after docetaxel. Two drugs (cabazitaxel and abiraterone) have recently been approved as second-line treatment after docetaxel failure in metastati
Externí odkaz:
https://doaj.org/article/201f290226824043b29bfa2930d60af4
Autor:
Carmen Salvador Coloma, Angel Segura Huerta, Óscar Mauricio Niño Gómez, Gema Bruixola Campos, Encarnación Reche Santos
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 2, Pp 391-396 (2013)
Case Reports in Oncology
Case Reports in Oncology
Introduction: To date, there are no guidelines for a rational and more favourable sequence of treatment after docetaxel. Two drugs (cabazitaxel and abiraterone) have recently been approved as second-line treatment after docetaxel failure in metastati
Autor:
Óscar Mauricio Niño Gómez, Koen Jerusalem, Miguel Pastor Borgoñón, Carmen Salvador Coloma, Encarnación Reche Santos, Joaquín Montalar Salcedo
Publikováno v:
Journal of NasoPharyngeal Carcinoma. 2
Introduction and objective: Nasopharyngeal carcinomas differ from other head and neck tumors. Patients have a higher rate of survival and thereby have a higher chance of presenting late toxicity, affecting their quality of life. We have tried to eval
Autor:
Óscar Mauricio Niño Gómez, Óscar Juan Vidal, Encarnación Reche Santos, Lydia Díez Langhetée, Mohamed Bennis, Carmen Salvador-Coloma
Publikováno v:
International Journal of Cancer Therapy and Oncology, Vol 3, Iss 3 (2015)
We present the case of a 72-year-old patient admitted on various occasions with symptoms of intestinal pseudo-obstruction. Extensive diagnostic tests eventually found that the patient had small-cell lung cancer associated with high anti-HU antibody t